From our survey

How to start a depression treatment conversation in St. Louis

Most people looking for help with depression in St. Louis do not begin with a clinic. They begin with a phone number already saved in their contacts.

When our survey asked 443 adults across ten Midwest states where they would turn first to pursue ketamine or esketamine therapy, most named an office they already visit: primary care for 56 percent, psychiatry or another mental health practice for 23 percent. Twelve percent would look it up themselves and 1 percent would ask a friend; 5 percent had no idea how to begin.

This guide follows that order, because a route people will actually take beats one that only looks efficient on paper.

Step one: the office you already have

Primary care is the usual entry point for good reason. Your medication history lives there, along with your chart, your allergy list, and the note from the last thing that did not work. If you want a referral a specialist will take seriously, that documentation is the asset.

Book the visit on purpose. When you call, say it is about depression that has not improved on medication, and ask for a longer visit or a behavioral health slot; practices across the metro handle this differently, and asking costs nothing. Before you go, write four things on one page and hand it over:

• Every antidepressant you have taken, with your best guess at the dose and the number of months on each.
• Why each one ended: side effects, no benefit, cost, or you simply stopped.
• What the last six months have looked like in specifics: sleep, appetite, work, the things you have stopped doing.
• Other diagnoses and prescriptions, including blood pressure medication, since it comes up in this conversation.

Step two: the referral question, asked precisely

"What do you think about ketamine" and "am I a candidate for esketamine, and if I am not, what should come first" are different questions, and the second gets a usable answer.

Esketamine, marketed as Spravato, has FDA approval tied to treatment-resistant depression, and every dose is supervised in a certified setting with monitoring afterward. Ketamine given by infusion, or sold for home use online, sits in a different regulatory category. Whether either suits you is a clinical decision, not a shopping one, and your physician should make the first call. For a concrete picture of the supervised version, Brain Recovery Centers lays out what Spravato visits involve.

If your primary care doctor does not manage this, ask who does. A named referral within the same system usually moves faster than a cold search and keeps your records traveling with you.

Step three: call your insurance before you call a clinic

Coverage dominated the survey. Insurance was a top-two provider priority for 85 percent of respondents, well above nearness at 43 percent, and for 65 percent it would settle or strongly shape whether they went through with treatment. People will also work for coverage: offered an insured path with more paperwork or a quicker self-pay start, a narrow majority of 51 percent chose the paperwork, while 23 percent would cover it themselves and 26 percent could not decide.

If you are calling around the St. Louis area, the payer mix matters. With multiple answers allowed, commercial coverage reached 39 percent, Medicaid 37, and Medicare 23, while TRICARE (5 percent) and no insurance at all (9 percent) were smaller slices; 2 percent declined to say. A clinic that takes only commercial plans is closed to much of this region, so ask about your plan by name instead of asking whether they "take insurance."

Ask the member services line four things. Is esketamine covered under the medical or pharmacy benefit? Does it need prior authorization, and how many earlier medication trials must be documented? Which certified sites nearby are in network? What will I owe per session after the deductible, and is monitoring time billed separately?

Step four: decide how you want care delivered

Preferences were clearer than we expected. Going to a clinic in person appealed to 44 percent of respondents and home telehealth to 22 percent; another 23 percent would open at a clinic and later continue from home, while 11 percent had no preference.

In person carries a scheduling reality in the metro: supervised sessions require a ride home, and the monitoring period is not optional. Weigh the commute across county lines, the parking, and the time off work before deciding a location truly works.

If you do not have a primary care doctor

The 5 percent of respondents without a starting point deserve a route too. Federally qualified health centers in the region see patients on a sliding scale regardless of insurance, and the county health department can point you to behavioral health intake. With coverage, your plan's directory lists in-network practices taking new patients, and member services can often book for you. Establishing primary care is slower than calling a clinic, but it puts the survey's biggest finding to work: their own doctor's recommendation was the persuader for 74 percent of respondents, an ad for 2 percent.

A note on the words you use

The 319 search phrases our respondents offered were nearly all symptoms and appeals, not treatment names: "ptsd treatments," "help with mental health," "how to overcome depression." You need no clinical vocabulary. Describing what your days feel like is enough and often more useful to a clinician than a treatment request.

Nothing here is medical advice, and no treatment on this page is recommended to you. Suitability rests on your history and current health, and a clinician decides it.

Before you close this page: if depression has pushed you toward thoughts of suicide, that is an emergency, and it is treatable. From anywhere in the U.S., 988 by call or text brings a Lifeline counselor on the line, free, at any hour. Tell one person today, even if the words come out badly; help exists now, not only after the referral.

Methodology

We, the site's publisher, commissioned this study and covered its cost. Pollfish collected responses on its consumer panel until fieldwork ended June 23, 2026; the 443 respondents came from the public rather than any clinic, covered ages 18 through 64, and lived in Missouri or one of nine nearby states; none was screened for a depression diagnosis. On multi-select questions, each option's share is out of all respondents, which is why some lists exceed 100. Results reflect the panel's concluded validation.